Evidence map›Paper›PMID 36512408›Full record

ArticleThe Journal of clinical investigation2023

LepRb+ cell-specific deletion of Slug mitigates obesity and nonalcoholic fatty liver disease in mice.

Min-Hyun Kim, Yuan Li, Qiantao Zheng, Lin Jiang, Martin G Myers, Wen-Shu Wu, Liangyou Rui

Open access · goldAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Min-Hyun KimDepartment of Molecular & Integrative Physiology.
Yuan LiDepartment of Molecular & Integrative Physiology.
Qiantao ZhengDepartment of Molecular & Integrative Physiology.
Lin JiangDepartment of Molecular & Integrative Physiology.
Martin G MyersDepartment of Molecular & Integrative Physiology.
Wen-Shu WuDivision of Hematology/Oncology, Department of Medicine, University of Illinois Cancer Center, University of Illinois at Chicago, Chicago, Illinois, USA.
Liangyou RuiDepartment of Molecular & Integrative Physiology.
Laboratoire d’immunologie intégrative du cancer · FRUniversity of Michigan · USUniversity of Illinois Chicago · US

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WILLIAM H HERMAN · 2013 to 2026
$24.3M
Pilot and Feasibility (P and F) ProgramP30DK089503 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Kanakadurga Singer · 2010 to 2026
$20.3M
MOLECULAR DETERMINANTS OF LEPTIN RECEPTOR/JAK2 SIGNALINGR01DK056731 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MYERS, MARTIN G · 1999 to 2025
$6.0M
The Role of Hypothalamic Slug in the Regulation of Leptin Sensitivity, Energy Balance, and Body WeightR01DK114220 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RUI, LIANGYOU · 2017 to 2024
$4.2M
Role of adipose mRNA modifications in metabolic diseaseR01DK130111 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LIANGYOU RUI · 2022 to 2026
$2.4M
Role of NF-kB-induce kinase (NIK) in liver diseasesR01DK115646 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RUI, LIANGYOU · 2017 to 2020
$1.7M
Role of hepatic Mettl14 pathways in liver metabolism and body metabolic homeostasisR01DK127568 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RUI, LIANGYOU · 2021 to 2023
$1.2M
Regulation of body weight, energy expenditure, and nutrient metabolism by hypothalamic Slug (Snai2) neural circuitsF32DK120111 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KIM, MIN HYUN · 2018 to 2021
$220k
NIDDK NIH HHS F32 DK120111NIDDK NIH HHS P30 DK020572NIDDK NIH HHS P30 DK089503NIDDK NIH HHS R01 DK056731NIDDK NIH HHS R01 DK114220NIDDK NIH HHS R01 DK115646NIDDK NIH HHS R01 DK127568NIDDK NIH HHS R01 DK130111
6 · The paper itself

Abstract

Leptin exerts its biological actions by activating the long-form leptin receptor (LepRb). LepRb signaling impairment and leptin resistance are believed to cause obesity. The transcription factor Slug - also known as Snai2 - recruits epigenetic modifiers and regulates gene expression by an epigenetic mechanism; however, its epigenetic action has not been explored in leptin resistance. Here, we uncover a proobesity function of neuronal Slug. Hypothalamic Slug was upregulated in obese mice. LepRb+ cell-specific Slug-knockout (SlugΔLepRb) mice were resistant to diet-induced obesity, type 2 diabetes, and liver steatosis and experienced decreased food intake and increased fat thermogenesis. Leptin stimulated hypothalamic Stat3 phosphorylation and weight loss to a markedly higher level in SlugΔLepRb than in Slugfl/fl mice, even before their body weight divergence. Conversely, hypothalamic LepRb+ neuron-specific overexpression of Slug, mediated by AAV-hSyn-DIO-Slug transduction, induced leptin resistance, obesity, and metabolic disorders in mice on a chow diet. At the genomic level, Slug bound to and repressed the LepRb promoter, thereby inhibiting LepRb transcription. Consistently, Slug deficiency decreased methylation of LepRb promoter H3K27, a repressive epigenetic mark, and increased LepRb mRNA levels in the hypothalamus. Collectively, these results unravel what we believe to be a previously unrecognized hypothalamic neuronal Slug/epigenetic reprogramming/leptin resistance axis that promotes energy imbalance, obesity, and metabolic disease.

Indexed as

Non-alcoholic Fatty Liver DiseaseObesityReceptors, LeptinSnail Family Transcription FactorsAnimalsDiabetes Mellitus, Type 2HypothalamusLeptinMiceSTAT3 Transcription FactorLeptinReceptors, LeptinSnai2 protein, mouseSnail Family Transcription FactorsSTAT3 Transcription FactorCell BiologyDiabetesLeptinMetabolismObesity

Identifiers

PMID36512408
PMCPMC9927931
OpenAlexW4311283026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.